Chapel Hill startup focusing on precision health, oncology raises additional $1.8M
That brings the total raised to roughly $4.85 since December 2019. Eight investors contributed to the round.
Read More
cancer
As Justice Ginsburg fights pancreatic cancer, here’s a look at why the disease is so deadly
Pancreatic cancer, the third-leading cause of death from cancer in the United States in 2018, after lung and colorectal cancers, according to the National Cancer Institute, is back in the headlines. Here’s a look at the deadly disease.
Read More
New recommendations: Screen more women for gene mutations that can increase cancer risk
More women should be assessed for harmful mutations in the BRCA1 and BRCA2 genes that can increase risk of certain cancers, according to new recommendations.
Read More
FDA approves clinical trial for two-pronged Heat Biologics cancer treatment
The trial, expected to begin enrolling patients in the fourth quarter 2019, will test combining Heat’s engineered HS-130 and HS-110 cell lines.
Read More
Q&A: Real Magic’s Jesse Lipson shares his side about wife’s colon cancer battle
As part of a candid, two-part interview, Bell, 38, and her husband, Jesse Lipson, founder of Real Magic and ShareFile, talk about her decision to go public, and how it has impacted their lives and businesses.
Read More
Q&A 2: Brooks Bell talks about stepping down as CEO, what entrepreneurs can learn from her experience
In the second part of a candid interview, Bell, 38, talks about her decision to step away as CEO, her upcoming chemotherapy and what entrepreneurs can learn from her experience.
Read More
New cancer treatments may emerge from $30M bluebird bio, Gritstone deal
Collaboration deal between bluebird bio, which has a manufacturing facility in Durham, and Gritstone, may help target cancer therapies.
Read More
Promising new cancer therapy could beat back tumors with limited side effects
Scientists at the University of North Carolina School of Medicine and North Carolina State University have created an injectable gel-like scaffold that can hold a combination of chemo and immunotherapeutic drugs and deliver them locally to tumors. Researchers say the approach may “Beat back tumor development with limited side-effects.”
Read More
